NCT06703554

Brief Summary

Glucosyltransferases (Gtfs) play a crucial role in the pathogenesis of dental caries caused by Streptococcus mutans. Gtfs is recognized as an attractive target for effective therapeutic interventions aimed at inhibiting cariogenic biofilms. Objective: This study evaluates the antibacterial effects of sage extract compared to chlorhexidine mouthwashes on the expression of Gtf genes in S. mutans from salivary samples of high caries risk patients over a one-month follow-up, utilizing real-time polymerase chain reaction. Methodology: This clinical trial involves 42 participants with a high risk for caries, who are randomly divided into two groups of 21 subjects each.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 2, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 10, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 25, 2024

Completed
Last Updated

May 7, 2025

Status Verified

May 1, 2025

Enrollment Period

5 months

First QC Date

November 10, 2024

Last Update Submit

May 5, 2025

Conditions

Keywords

High caries riskChlorohexidineReal-time PCR

Outcome Measures

Primary Outcomes (8)

  • real-time PCR

    S. Mutans, Gtf B, Gtf D

    1 week

  • real-time PCR

    S. Mutans, Gtf B, Gtf D

    2 weeks

  • real-time PCR

    S. Mutans, Gtf B, Gtf D

    3 weeks

  • real-time PCR

    S. Mutans, Gtf B, Gtf D

    4 weeks

  • Gene Expression

    S. Mutans, Gene Expression

    1 week

  • Gene Expression

    S. Mutans, Gene Expression

    2 weeks

  • Gene Expression

    S. Mutans, Gene Expression

    3 weeks

  • Gene Expression

    S. Mutans, Gene Expression

    4 weeks

Study Arms (2)

Sage oil mouthwash

EXPERIMENTAL

Sage oil obtained from a local market of herbal products in Egypt. In order to identify chemical composition of sage essential oils and overall purity, Gas Chromatography/ Mass Spectrometry analysis (GC/MS) performed

Other: Sage Oil Mouthwash

Chlorohexidine Mouthwash

ACTIVE COMPARATOR

0.12% chlorhexidine gluconate in a base containing water, 11.6% alcohol, glycerin, PEG-40 sorbitan diisostearate, flavor, and sodium saccharin

Biological: Chlorohexidine Mouthwash

Interventions

Sage oil obtained from a local market of herbal products in Egypt. In order to identify chemical composition of sage essential oils and overall purity, Gas Chromatography/ Mass Spectrometry analysis (GC/MS) performed

Also known as: Natural product
Sage oil mouthwash

0.12% chlorhexidine gluconate in a base containing water, 11.6% alcohol, glycerin, PEG-40 sorbitan diisostearate, flavor, and sodium saccharin

Also known as: CHX mouthwash
Chlorohexidine Mouthwash

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • medically free, high caries patient with DMFT

You may not qualify if:

  • pregnant and smokers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University

Cairo, Egypt

Location

MeSH Terms

Conditions

Dental CariesStomatognathic Diseases

Interventions

Biological Products

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth Diseases

Intervention Hierarchy (Ancestors)

Complex Mixtures

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
same bottles dark in color was used
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Sage Extract Natural product
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer at Conservative Department

Study Record Dates

First Submitted

November 10, 2024

First Posted

November 25, 2024

Study Start

January 2, 2024

Primary Completion

May 20, 2024

Study Completion

June 25, 2024

Last Updated

May 7, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations